ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -99.1% | 400 | -97.6% | 0.00% | -100.0% |
| Q3 2018 | $225,000 | +21.0% | 16,609 | +5.5% | 0.00% | -33.3% |
| Q2 2018 | $186,000 | +1966.7% | 15,742 | +1867.8% | 0.00% | – |
| Q1 2018 | $9,000 | +80.0% | 800 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 800 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |